Trial intelligence / Profile preview

Optimization of treatment for polycystic ovary syndrome with liver channel damp-heat syndrome

ChiCTR-TRC-13004091Phase 4Recruiting

Sponsor
Changhai Hospital
Start
Oct 2013
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, open-label trial of ethinyl estradiol + cyproterone in polycystic ovary syndrome (PCOS) (3 arms), sponsored by Changhai Hospital. Primary endpoint: Ovulation rate. Started Oct 2013; status: recruiting.

02

Drugs

ethinyl estradiol + cyproterone
03

Conditions

polycystic ovary syndrome (PCOS)

Beyond the preview

Go deeper on ChiCTR-TRC-13004091.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR-TRC-13004091.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call